Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ADU-S100 (MIW815) disodium salt is an activator of stimulator of interferon genes (STING).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 535.00 | |
50 mg | Inquiry | Inquiry | |
100 mg | Inquiry | Inquiry |
Description | ADU-S100 (MIW815) disodium salt is an activator of stimulator of interferon genes (STING). |
In vitro | ADU-S100 shows enhanced type I IFN production over CDA in THP-1 human monocytes. ADU-S100 induces the highest expression of IFN-β and the pro-inflammatory cytokines TNF-α, IL-6, and MCP-1 on a molar equivalent basis, as compared to endogenous ML cGAMP and the TLR3 agonist poly I:C. ADU-S100 is also found to induce aggregation of STING and induce phosphorylation of TBK1 and IRF3 in mouse bone marrow macrophage (BMM). ADU-S100 induces significantly higher levels of IFN-α when compared to ML cGAMP. |
In vivo | ADU-S100 demonstrates superior anti-tumor efficacy compared to the endogenous molecule ML cGAMP. Upon conducting a dose-response analysis in B16 tumor-bearing mice with the ADU-S100 compound, an optimal dose for maximal antitumor activity was identified. This optimal dose not only elicits heightened tumor antigen-specific CD8+ T cell responses but also significantly enhances long-term survival rates to 50%. |
Cell Research | Cryopreserved hPBMCs are thawed and 1×10^6 cells per well are plated in a 96 well plate in RPMI media supplemented with 10% FBS, 1% non-essential amino acids, 1% penicillin/streptomycin, L-glutamine, 10 mM HEPES buffer, 1 mM Sodium Pyruvate, 0.055 mM β-ME at 37°C with 5% CO2. Cells are stimulated with 10 μM ADU-S100 or ML cGAMP for 6 hours and supernatants are harvested. Supernatants are diluted 1:2 and assayed for IFN-α protein using Cytometric Bead Array (CBA) Human Flex Set. Data is collected using a FACSVerse cytometer. |
Animal Research | WT C57BL/6 mice are inoculated with 5×10^4 B16.F10 cells in the left flank (n=8). When tumor volumes are 100 mm3 mice receive three IT doses of either ML RR-S2 CDG (25 μg), ADU-S100 (50 μg), or HBSS as control. WT C57BL/6 mice are inoculated with 5×10^4 B16.F10 cells in the left flank (n=5). When tumor volumes are 100 mm3 they received three IT doses of ADU-S100 at 5, 25, 50, or 100 μg or HBSS as control. WT C57BL/6 mice are inoculated with 5×104 B16.F10 cells in the left flank (n=8). When tumor volumes are 100 mm3 they receive three IT doses of 100 μg ADU-S100 or HBSS as control. Treatments are administered on days 13, 17, and 20 and tumor measurements are taken twice weekly. Results are shown as percent survival by Log-rank (Mantel-Cox) test (A and C). |
Synonyms | ML RR-S2 CDA disodium salt, MIW815 disodium salt |
Molecular Weight | 736.52 |
Formula | C20H24N10Na2O10P2S2 |
CAS No. | 1638750-95-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 300 mg/mL (408.44 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ADU-S100 disodium salt 1638750-95-4 Others ADU-S 100 ML RR-S2 CDA MIW 815 ML RR-S2 CDA disodium salt ADU-S100 ADUS100 disodium salt MIW815 MIW815 disodium ADU S100 disodium salt ADU-S100 disodium ADU-S-100 disodium salt MIW815 disodium salt ML RR-S2 CDA disodium MIW-815 ADU-S-100 inhibitor inhibit